Aster DM Healthcare Share price Target 2025, 2026, to 2030

Aster DM Healthcare Ltd, founded in 1987 by Dr. Azad Moopen, is a leading healthcare provider with a strong presence in the Middle East and India. Over the years, the company has grown into a prominent name in the healthcare industry, widely recognized for its comprehensive range of services and commitment to quality. From its humble beginnings, Aster DM Healthcare has expanded its operations significantly, now offering a wide spectrum of medical services across various care levels, including primary, secondary, tertiary, and quaternary healthcare.

Aster DM Healthcare operates through a network of 19 hospitals, with a combined capacity of nearly 5,000 beds, along with a large number of clinics, pharmacies, and diagnostic labs. This infrastructure enables the company to cater to a diverse population and meet a wide range of healthcare needs, from preventive and primary care to advanced and specialized treatments. The company’s focus on integrating state-of-the-art medical technology and highly skilled medical professionals has positioned it as a reliable and trusted healthcare provider in its regions of operation. With a commitment to patient-centered care, Aster DM Healthcare continues to expand its reach and services to make quality healthcare more accessible.

Shareholdings Patterns of Aster DM Healthcare Ltd

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters +	41.88%	41.88%	41.88%	41.88%	41.88%
FIIs +	40.22%	41.00%	33.48%	27.08%	23.86%
DIIs +	7.64%	7.15%	13.70%	16.35%	20.91%
Public +	9.85%	9.61%	10.59%	14.38%	13.05%
Others +	0.41%	0.37%	0.35%	0.32%	0.30%
No. of Shareholders	67,673	67,331	80,931	2,06,660	1,74,171

The shareholding pattern of Aster DM Healthcare Ltd has shown some significant changes over the year from September 2023 to September 2024. Promoters consistently retained a substantial share of 41.88% throughout the period, indicating stable ownership. Foreign Institutional Investors (FIIs) initially held 40.22% in September 2023, which rose slightly to 41.00% in December 2023 but then steadily declined to 23.86% by September 2024. In contrast, Domestic Institutional Investors (DIIs) increased their stake, starting at 7.64% in September 2023 and reaching 20.91% by September 2024, suggesting heightened domestic institutional interest in Aster DM Healthcare Ltd. Public holdings fluctuated, beginning at 9.85%, peaking at 14.38% in June 2024, and settling at 13.05% in September 2024. The “Others” category maintained a minimal presence, slightly reducing from 0.41% to 0.30% over the year. The total number of shareholders also saw a significant increase, especially from March 2024, peaking at 206,660 in June before settling at 174,171 in September 2024, reflecting a growing interest in Aster DM Healthcare Ltd among investors.

Expansion Plans

Aster DM Healthcare is set to expand its capacity significantly, aiming to add over 1,800 beds by FY27. A key project in this plan is the Aster Women and Child facility in Hyderabad, which will feature 300 beds dedicated to maternal and pediatric care. This expansion not only addresses the rising demand for healthcare services but also enhances the quality of care provided, with a focus on specialized treatments for women and children. Overall, these initiatives underscore Aster’s commitment to improving healthcare accessibility and outcomes in the regions it serves.

How to Purchase Aster DM Healthcare Ltd Shares in India?

Below are the trading platforms that you can use to purchase Aster DM Healthcare Ltd shares:

➤ Zerodha

➤ Upstox

➤ Groww

➤ AngelOne

➤ ICICIDirect

Aster DM Healthcare Ltd Share Price Target 2024 – 2030

Aster DM Healthcare Ltd Share Price Target 2024

When	Maximum Price	Minimum Price
November 2024	494.05	429.61
December 2024	498.99	433.91

As we approach the end of 2024, Aster DM Healthcare Ltd’s stock price is expected to show potential fluctuations. In November, the maximum price may reach around ₹494.05, while the minimum is anticipated to be approximately ₹429.61. Moving into December, Aster DM Healthcare Ltd’s stock might see a slight increase, with a projected maximum of ₹498.99 and a minimum of ₹433.91.

Aster DM Healthcare Ltd Share Price Target 2025

When	Maximum Price	Minimum Price
January 2025	503.98	387.68
February 2025	509.08	391.60
March 2025	519.77	399.82
April 2025	514.62	395.86
May 2025	499.63	384.33
June 2025	522.11	401.63
July 2025	511.88	393.75
August 2025	527.71	405.93
September 2025	534.04	410.80
October 2025	547.93	421.48
November 2025	561.62	432.02
December 2025	586.90	451.46

As we move through 2025, Aster DM Healthcare Ltd’s stock is expected to fluctuate with potential highs reaching ₹503.98 in January, gradually increasing to ₹586.90 by December.

Aster DM Healthcare Ltd Share Price Prediction 2026

When	Maximum Price	Minimum Price
January 2026	604.50	465.00
February 2026	589.39	453.38
March 2026	601.18	462.45
April 2026	613.45	471.88
May 2026	607.37	467.21
June 2026	622.56	478.89
July 2026	610.35	469.50
August 2026	629.23	484.02
September 2026	641.81	493.70
October 2026	658.50	506.54
November 2026	674.96	519.20
December 2026	691.84	532.18

Aster DM Healthcare Ltd Share Price Target 2027

When	Maximum Price	Minimum Price
January 2027	698.75	537.50
February 2027	716.67	551.29
March 2027	744.62	572.79
April 2027	730.02	561.55
May 2027	708.76	545.20
June 2027	740.65	569.73
July 2027	726.13	558.56
August 2027	748.59	575.84
September 2027	774.79	595.99
October 2027	794.93	611.49
November 2027	814.81	626.77
December 2027	835.18	642.44

Aster DM Healthcare Ltd Share Price Target 2028

When	Maximum Price	Minimum Price
January 2028	851.88	655.29
February 2028	873.72	672.09
March 2028	907.80	698.31
April 2028	890.00	684.61
May 2028	864.08	664.67
June 2028	902.96	694.58
July 2028	885.25	680.96
August 2028	912.63	702.03
September 2028	944.58	726.60
October 2028	969.13	745.49
November 2028	993.36	764.12
December 2028	1,018.20	783.23

Aster DM Healthcare Ltd Share Price Prediction 2029

When	Maximum Price	Minimum Price
January 2029	1,038.56	798.89
February 2029	1,065.19	819.38
March 2029	1,106.73	851.33
April 2029	1,085.03	834.64
May 2029	1,053.43	810.33
June 2029	1,100.83	846.79
July 2029	1,079.25	830.19
August 2029	1,112.63	855.87
September 2029	1,151.57	885.82
October 2029	1,181.51	908.85
November 2029	1,211.05	931.58
December 2029	1,241.32	954.86

Aster DM Healthcare Ltd Share Price Target 2030

When	Maximum Price	Minimum Price
January 2030	1,266.15	973.96
February 2030	1,298.62	998.94
March 2030	1,349.26	1,037.89
April 2030	1,322.81	1,017.54
May 2030	1,284.28	987.91
June 2030	1,342.07	1,032.36
July 2030	1,315.75	1,012.12
August 2030	1,356.45	1,043.42
September 2030	1,403.92	1,079.94
October 2030	1,440.43	1,108.02
November 2030	1,476.44	1,135.72
December 2030	1,513.35	1,164.11

Financial Condition of Aster DM Healthcare Ltd

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales +	8,652	8,608	10,253	2,994	3,699	4,017
Expenses +	7,187	7,506	8,720	2,547	3,124	3,333
Operating Profit	1,465	1,103	1,533	447	575	684
OPM %	17%	13%	15%	15%	16%	17%
Other Income +	-158	53	51	353	32	5,268
Interest	391	334	307	96	119	116
Depreciation	586	618	641	192	220	238
Profit before tax	330	205	637	511	268	5,599
Tax %	5%	13%	6%	7%	21%
Net Profit +	315	178	601	475	212	5,465
EPS in Rs	5.54	2.96	10.53	8.51	2.59	108.05
Dividend Payout %	0%	0%	0%	0%	77%

The financial performance of Aster DM Healthcare Ltd has experienced shifts from March 2020 through the trailing twelve months (TTM). Sales showed a growth trajectory from ₹8,652 crore in March 2020 to ₹10,253 crore in March 2022, before dipping to ₹2,994 crore in March 2023 and then recovering to ₹4,017 crore in TTM. Expenses followed a similar pattern, reaching ₹8,720 crore in March 2022, decreasing to ₹2,547 crore in March 2023, and rising to ₹3,333 crore in TTM.

Operating profit saw fluctuations, standing at ₹1,465 crore in March 2020 and reaching ₹684 crore in TTM, with an Operating Profit Margin (OPM) stabilizing around 15-17%. Other Income, unusually high in TTM at ₹5,268 crore, significantly impacted the Profit Before Tax (PBT), which soared to ₹5,599 crore, largely above historical levels. Interest expenses remained contained, while depreciation showed a slight increase over the period.

The company’s net profit witnessed significant variations, from ₹315 crore in March 2020 to an impressive ₹5,465 crore in TTM, mainly driven by higher other income. Earnings per share (EPS) reflected these trends, peaking at ₹108.05 in TTM. Aster DM Healthcare Ltd also declared a dividend payout for the first time in March 2024 at 77%, underscoring its strong financial year.